GRID therapy for extremity soft tissue sarcoma
Part of Cancer clinical trials.
This trial tests a special type of radiation called GRID therapy for soft tissue sarcomas in the arm or leg. It may be an option for people who have not had radiation to that area before and whose tumor was not completely removed by surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and willing to give consent.
- You have a soft tissue sarcoma in your arm or leg that was confirmed by a biopsy or surgery (but not completely removed).
- You have not had radiation to that area before.
- You have not had a complete surgical removal of the tumor or a recurrence after surgery.
- You do not have a serious wound, ulcer, or bone fracture in the treatment limb in the last 5 years, significant lymphedema, or a collagen vascular disease like lupus or scleroderma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
This trial tests a combination of a PARP inhibitor drug, targeted radiation (SBRT), and immunotherapy for people with advanced sarcoma that has spread. It aims to see if this triple therapy can shrink tumors or slow the disease.
This trial studies whether adding an exercise program helps people with soft tissue sarcoma in an arm or leg during a planned treatment course. The treatment they look at is radiation before surgery, then surgery to remove the tumor, and they want to see how exercise affects outcomes and recovery.
This trial tests a way of giving palliative radiation using a “grid” to treat advanced tumors that are large, resistant to standard radiation, or already needed more than one palliative radiation session. It may help better control symptoms when a cure is not the goal.
This trial tests a personalized (“adaptive”) radiation plan before surgery for high-grade soft-tissue sarcoma that can be removed. It may help shrink the tumor and improve how well surgery can treat the cancer.
This trial tests a special type of radiation called grid therapy for people with stage IV non-small cell lung cancer that has grown after immunotherapy or chemoimmunotherapy. It aims to see if this approach can help control tumors that are larger than 3 centimeters outside the brain.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.